Enzymatic O-GlcNAcylation of alpha-synuclein reduces aggregation and increases SDS-resistant soluble oligomers

doi:10.1016/j.neulet.2017.06.034

CAS OpenIR > 中科院上海应用物理研究所2011-2019年

	Enzymatic O-GlcNAcylation of alpha-synuclein reduces aggregation and increases SDS-resistant soluble oligomers
	Zhang, JM; Lei, HZ; Chen, YB; Ma, YT; Jiang, F; Tan, JQ; Zhang, Y; Li, JD
	2017
Source Publication	NEUROSCIENCE LETTERS
ISSN	0304-3940
Volume	655 Issue:-Pages:90-94
Subtype	期刊论文
Abstract	Neurodegenerative diseases including dementia with Lewy bodies, Lewy body variant of Alzheimer's disease, and Parkinson's disease are associated with the aberrant aggregation of alpha-synuclein, which is influenced by several post-translational modifications (PTM5). O-GlcNAcylation is one PTM that has an important role in many fundamental processes. The O-GlcNAcylation of endogenous a-synuclein at residues 53, 64, 72 and 87 has been reported in an unbiased mass spectrum analysis. The consequences of O-GlcNAcylation at residues 72 or 87 have been studied by using a synthetic a-synuclein bearing O-GlcNAcylation at threonine residue 72 or serine 87, respectively. O-GlcNAcylation at Thr72 or Ser87 suppresses the aggregation of alpha-synuclein. However, the effect of enzymatic O-GlcNAcylation of otsynuclein at multiple residues is not clear. Here, we successfully generated O-GlcNAcylated alpha-synuclein by co-expressing a shorter form of OGT (sOGT) with a-synuclein. The O-GlcNAcylation inhibited asynuclein aggregation and promoted the formation of soluble SDS-resistant and Thioflavine T negative oligomers. Our data warrant further studies on the role of O-GlcNAcylation in the progression/treatment of Parkinson's disease in animal models. (C) 2017 Elsevier B.V. All rights reserved.
Keyword	Linked N-acetylglucosamine Parkinsons-disease Membrane Interactions Mass-spectrometry Toxicity Brain Phosphorylation Ubiquitination Proteins Form
DOI	10.1016/j.neulet.2017.06.034
Indexed By	SCI
WOS Keyword	LINKED N-ACETYLGLUCOSAMINE ; PARKINSONS-DISEASE ; MEMBRANE INTERACTIONS ; MASS-SPECTROMETRY ; TOXICITY ; BRAIN ; PHOSPHORYLATION ; UBIQUITINATION ; PROTEINS ; FORM
Language	英语
WOS ID	WOS:000407663200014
Citation statistics	Cited Times:4[WOS] [WOS Record] [Related Records in WOS]
Document Type	期刊论文
Identifier	http://ir.sinap.ac.cn/handle/331007/28643
Collection	中科院上海应用物理研究所2011-2019年
Recommended Citation GB/T 7714	Zhang, JM,Lei, HZ,Chen, YB,et al. Enzymatic O-GlcNAcylation of alpha-synuclein reduces aggregation and increases SDS-resistant soluble oligomers[J]. NEUROSCIENCE LETTERS,2017,655(-):90-94.
APA	Zhang, JM.,Lei, HZ.,Chen, YB.,Ma, YT.,Jiang, F.,...&Li, JD.(2017).Enzymatic O-GlcNAcylation of alpha-synuclein reduces aggregation and increases SDS-resistant soluble oligomers.NEUROSCIENCE LETTERS,655(-),90-94.
MLA	Zhang, JM,et al."Enzymatic O-GlcNAcylation of alpha-synuclein reduces aggregation and increases SDS-resistant soluble oligomers".NEUROSCIENCE LETTERS 655.-(2017):90-94.

Files in This Item:
File Name/Size	DocType	Version	Access	License
Enzymatic O-GlcNAcyl（890KB）	期刊论文	作者接受稿	开放获取	CC BY-NC-SA	View Download

File name:	Enzymatic O-GlcNAcylation of alpha-synuclein reduces aggregation and increases SDS-resistant soluble oligomers.pdf
Format:	Adobe PDF

If you have any objections to this item, please fill out the form below and the administrator will contact you as soon as possible.
Content:
Email：	*
Institution:
Verification Code:	Refresh

Any comments and suggestions are welcomed.
Title:	*
Content:
Email：	*
Verification Code:	Refresh

中国科学院上海应用物理研究所机构知识库